Publications by authors named "David Karpf"

Claim this Profile
R
Response to Letter to the Editor From Malozowski: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Zhengning Lin, David B Karpf

J Clin Endocrinol Metab· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Letter to the Editor From L. Sävendahl et al: "Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial".
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, David B Karpf

J Clin Endocrinol Metab· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PaTH Forward: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial of TransCon PTH in Adult Hypoparathyroidism.
Aliya A Khan, Lars Rejnmark, Mishaela Rubin, Peter Schwarz, Tamara Vokes, David B Karpf

J Clin Endocrinol Metab· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weekly Lonapegsomatropin in Treatment-Naïve Children With Growth Hormone Deficiency: The Phase 3 heiGHt Trial.
Paul S Thornton, Aristides K Maniatis, Elena Aghajanova, Elena Chertok, Elpis Vlachopapadopoulou, David B Karpf

J Clin Endocrinol Metab· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact).
Meryl Brod, Laura Tesler Waldman, Alden Smith, David Karpf

Qual Life Res· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized Double-Blind Placebo-Controlled First-In-Human Phase 1 Trial of TransCon PTH in Healthy Adults.
David B Karpf, Susanne Pihl, Sanchita Mourya, Eva Mortensen, Eshwari Kovoor

J Bone Miner Res· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing the Patient Experience of Hypoparathyroidism Symptoms: Development of the Hypoparathyroidism Patient Experience Scale-Symptom (HPES-Symptom).
Meryl Brod, Laura Tesler Waldman, Alden Smith, David Karpf

Patient· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism.
Lars Holten-Andersen, Susanne Pihl, Caroline E Rasmussen, Joachim Zettler, Guillaume Maitro, David B Karpf

J Bone Miner Res· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The rationale and design of TransCon Growth Hormone for the treatment of growth hormone deficiency.
Kennett Sprogøe, Eva Mortensen, David B Karpf, Jonathan A Leff

Endocr Connect· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of the PPAR-δ agonist MBX-8025 on atherogenic dyslipidemia.
Yun-Jung Choi, Brian K Roberts, Xueyan Wang, J Casey Geaney, Sue Naim, David B Karpf

Atherosclerosis· February 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MBX-8025, a novel peroxisome proliferator receptor-delta agonist: lipid and other metabolic effects in dyslipidemic overweight patients treated with and without atorvastatin.
Harold E Bays, Sherwyn Schwartz, Thomas Littlejohn, Boris Kerzner, Ronald M Krauss, David B Karpf

J Clin Endocrinol Metab· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The cost-effectiveness of therapy with teriparatide and alendronate in women with severe osteoporosis.
Hau Liu, Kaleb Michaud, Smita Nayak, David B Karpf, Douglas K Owens

Arch Intern Med· June 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs.
Steven R Cummings, David B Karpf, Fran Harris, Harry K Genant, Kristine Ensrud

Am J Med· March 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis